bakuchiol and Lymphoma--T-Cell

bakuchiol has been researched along with Lymphoma--T-Cell* in 1 studies

Other Studies

1 other study(ies) available for bakuchiol and Lymphoma--T-Cell

ArticleYear
Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2005, Volume: 62, Issue:3

    Bakuchiol, extracted from the plant Psoralea corylifolia, has been proven to have anti-tumor, cytotoxic, anti-microbial and anti-inflammatory activity. In order to study if radiolabeled bakuchiol exhibits enhanced cytotoxicity, bakuchiol was radiolabeled with 125I. In-vitro uptake studies of 125I-bakuchiol were carried out using LS-A (lymphosarcoma) and barcl-95 (radiation-induced thymic lymphoma) ascitic and solid tumor cells of murine origin. In both LS-A and barcl-95, 125I-bakuchiol showed significant uptake. Viability studies showed that the radioiodinated compound showed greater cytotoxic effect than bakuchiol.

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Iodine Radioisotopes; Isotope Labeling; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Mice; Phenols; Plant Extracts; Psoralea; Radiopharmaceuticals

2005